IFNG and cranioectodermal dysplasia: The fact that some participants treated with ZED1227 in the PGCd group still showed a significant epithelial IFNγ response (Fig. 3c), as a sign of active residual CeD pathophysiology prompted us to study factors behind the incomplete response to treatment.